Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin versus pregabalin versus placebo for attenuation of intubation-related hemodynamic stress in cancer patients
PACTR202511691908001Completed
- Sponsor
- Cairo University
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of pregabalin, melatonin and Placebo-COD Research Private Ltd in cancer, sponsored by Cairo University. Primary endpoint: Change in heart rate. Started Nov 2023; status: completed.
02
Drugs
pregabalinmelatoninPlacebo-COD Research Private Ltd
03
Conditions
cancer
Beyond the preview
Go deeper on PACTR202511691908001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511691908001.